Events and Webinars
Upcoming Events and Webinars
24 Hours to Save AIDS Research
Webinar
HIV Prevention Re-mix: Current tools, new tools, same goal
Webinar
20th European AIDS Conference (EACS 2025)
International Conference on Family Planning (ICFP 2025)
International Conference on AIDS and STIs in Africa (ICASA 2025)
Past Events
showing 1-10 of 466
Will Lenacapavir be a Lever or a Let-Down? Lessons, Resources and Considerations for Implementation in the United States
Approved in July, lenacapavir for PrEP has tremendous potential to increase access and engagement in the United States, reaching individuals who have been unable to embrace PrEP in its previous formulations. The Choice Agenda and the HIV BLUPrInt...
South African AIDS Conference (SAAIDS)
The 12th SAAIDS Conference 2025, under the theme: Unite for Change – Empower Communities and Redefine Priorities for HIV/AIDS will be held in Johannesburg 8-11 September. Resources If you’re attending, don’t miss a keynote plenary...
Prevention Option:
IMPT LET’s Talk MPTs “Introducing the Dual Prevention Pill: Lessons Learned and What’s Next for Regulatory, Research, and Rollout” Webinar
Join an engaging session on the Dual Prevention Pill (DPP), featuring Kate Segal (AVAC), Barbara Friedland (Population Council), and Wawira Nyagah (AVAC). Speakers will highlight the product pipeline, the regulatory pathway, and the implementation...
Key Messages from IAS 2025
This webinar will provide participants with scientific, policy, funding and community highlights from IAS 2025, the 13th IAS Conference on HIV Science, held in Kigali, Rwanda, in July. Attendees will gain a clearer understanding of the latest trends...
From Bench to Bedside—Together: Patient-Driven Innovation in Infectious Disease Clinical Trials
AVAC’s Mitchell Warren and Stacey Hannah will join Infectious Disease Alliance (IDA) and Esperity for a webinar on how patient-driven collaboration is enhancing the design, implementation, and impact of clinical trials in the field of...
New WHO Guidance on Lenacapavir for Prevention & HIV Testing for Long-Acting PrEP
This 60-minute webinar is intended for communities, providers, policy makers and advocates for PrEP, HIV prevention and HIV testing. We will provide an overview of the key takeaways and new guidance from newly released Guidelines on lenacapavir...
Reprioritization of Global Fund Programs: What it means for Community actors in Malaria, Tuberculosis and HIV
The Global Fund is working with Country Coordinating Mechanisms (CCMs) and Principal Recipients (PRs) to reprioritize activities under Grant Cycle 7 (GC7) due to reduced funding allocations. This process aims to safeguard essential HIV, TB, and...
Fight for our Lives Emergency Townhall
Join AVAC and GBGMC for the next “Fight For Our Lives” Emergency Town Hall to learn more about how the recent freeze on US government foreign assistance has impacted the availability of PrEP, including the rollout of injectable cabotegravir for...
PrEP Implementation — What’s worked and what are we learning
Pre-exposure prophylaxis (PrEP) has emerged as a critical tool in the global HIV prevention response. Despite its proven efficacy, global uptake of oral PrEP has been slower than anticipated, falling short of UNAIDS’ 2025 targets. However,...
Expanding HIV Prevention Options: Spotlight on new HIV prevention technologies
Join the International Community of Women Living with HIV Eastern Africa (ICWEA) to discuss the dapivirine vaginal ring, lenacapavir, and cabotegravir. Moderated by Lillian Mworeko and Dr. Lilian Benjamain Mwakyosi, speakers include:
showing 1-10 of 466